By Dean Seal Becton Dickinson raised its fiscal 2024 guidance slightly after reporting higher revenue in the first quarter, largely from its medical and.
By Denny Jacob Surmodics shares declined 10%, to $31.68, in what one analyst sees as a response to high expectations coming into the quarter. The stock is up.
By Denny Jacob Bausch Health on Thursday nominated two independent candidates for election to its board of directors at its annual shareholder meeting as.